Cargando…
Hepatocyte Growth Factor Enhances Antineoplastic Effect of 5-Fluorouracil by Increasing UPP1 Expression in HepG2 Cells
Aberrant activation of hepatocyte growth factor (HGF) and its receptor c-Met axis promotes tumor growth. Therefore, many clinical trials have been conducted. A phase 3 trial investigating a monoclonal antibody targeting HGF in combination with fluoropyrimidine-based chemotherapy had to be terminated...
Autores principales: | Okumura, Manabu, Iwakiri, Tomomi, Yoshikawa, Naoki, Nagatomo, Takao, Ayabe, Takanori, Tsuneyoshi, Isao, Ikeda, Ryuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409026/ https://www.ncbi.nlm.nih.gov/pubmed/36012373 http://dx.doi.org/10.3390/ijms23169108 |
Ejemplares similares
-
Differential Inhibite Effect of Xanthohumol on HepG2 Cells and
Primary Hepatocytes
por: Zhang, Xiuli, et al.
Publicado: (2022) -
Data on the expression of PEPCK in HepG2 hepatocytes transfected with miR-195
por: Yang, Won-Mo, et al.
Publicado: (2017) -
LHC-start skjuts upp – igen
Publicado: (2008) -
Inhibitory Effect of Gardenoside on Free Fatty Acid-Induced Steatosis in HepG2 Hepatocytes
por: Liang, Huiqing, et al.
Publicado: (2015) -
Data on the decreased expression of FOXO1 by miR-1271 in HepG2 hepatocytes
por: Yang, Won-Mo, et al.
Publicado: (2017)